BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

136 related articles for article (PubMed ID: 16333608)

  • 1. VIM-2 metallo-beta-lactamase in Achromobacter xylosoxidans in Europe.
    Sofianou D; Markogiannakis A; Metzidie E; Pournaras S; Tsakris A
    Eur J Clin Microbiol Infect Dis; 2005 Dec; 24(12):854-5. PubMed ID: 16333608
    [No Abstract]   [Full Text] [Related]  

  • 2. Identification of Achromobacter xylosoxidans by detection of the bla(OXA-114-like) gene intrinsic in this species.
    Turton JF; Mustafa N; Shah J; Hampton CV; Pike R; Kenna DT
    Diagn Microbiol Infect Dis; 2011 Jul; 70(3):408-11. PubMed ID: 21497041
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Molecular characterization of IMP-type metallo-β-lactamases among multidrug-resistant Achromobacter xylosoxidans.
    Yamamoto M; Nagao M; Hotta G; Matsumura Y; Matsushima A; Ito Y; Takakura S; Ichiyama S
    J Antimicrob Chemother; 2012 Sep; 67(9):2110-3. PubMed ID: 22577105
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Genetic and biochemical characterization of a novel metallo-β-lactamase, TMB-1, from an Achromobacter xylosoxidans strain isolated in Tripoli, Libya.
    El Salabi A; Borra PS; Toleman MA; Samuelsen Ø; Walsh TR
    Antimicrob Agents Chemother; 2012 May; 56(5):2241-5. PubMed ID: 22290947
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Imipenem-resistant Achromobacter xylosoxidans carrying blaVIM-2-containing class 1 integron.
    Shin KS; Han K; Lee J; Hong SB; Son BR; Youn SJ; Kim J; Shin HS
    Diagn Microbiol Infect Dis; 2005 Nov; 53(3):215-20. PubMed ID: 16260111
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Presence of OXA-type enzymes in Achromobacter insuavis and A. dolens.
    Traglia G; Papalia M; Almuzara M; Gutkind G; Centrón D; Vay C; Radice M; Ramírez MS
    Curr Microbiol; 2014 Oct; 69(4):501-6. PubMed ID: 24894902
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Shared genotypes of Achromobacter xylosoxidans strains isolated from patients at a cystic fibrosis rehabilitation center.
    Van Daele S; Verhelst R; Claeys G; Verschraegen G; Franckx H; Van Simaey L; de Ganck C; De Baets F; Vaneechoutte M
    J Clin Microbiol; 2005 Jun; 43(6):2998-3002. PubMed ID: 15956444
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Complicated intra-abdominal infection caused by extended drug-resistant Achromobacter xylosoxidans.
    Teng SO; Ou TY; Hsieh YC; Lee WC; Lin YC; Lee WS
    J Microbiol Immunol Infect; 2009 Apr; 42(2):176-80. PubMed ID: 19597652
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Evaluation of the Immunochromatographic NG-Test Carba 5 for Rapid Identification of Carbapenemase in Nonfermenters.
    Potron A; Fournier D; Emeraud C; Triponney P; Plésiat P; Naas T; Dortet L
    Antimicrob Agents Chemother; 2019 Sep; 63(9):. PubMed ID: 31285233
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Characterization of a naturally occurring class D beta-lactamase from Achromobacter xylosoxidans.
    Doi Y; Poirel L; Paterson DL; Nordmann P
    Antimicrob Agents Chemother; 2008 Jun; 52(6):1952-6. PubMed ID: 18362192
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Fluorescence in situ hybridization for rapid identification of Achromobacter xylosoxidans and Alcaligenes faecalis recovered from cystic fibrosis patients.
    Wellinghausen N; Wirths B; Poppert S
    J Clin Microbiol; 2006 Sep; 44(9):3415-7. PubMed ID: 16954289
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Interspecies Dissemination of a Mobilizable Plasmid Harboring blaIMP-19 and the Possibility of Horizontal Gene Transfer in a Single Patient.
    Yamamoto M; Matsumura Y; Gomi R; Matsuda T; Tanaka M; Nagao M; Takakura S; Uemoto S; Ichiyama S
    Antimicrob Agents Chemother; 2016 Sep; 60(9):5412-9. PubMed ID: 27381397
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Epidemiological typing of clinical isolates of Achromobacter xylosoxidans: comparison of phenotypic and genotypic methods.
    Kaur M; Ray P; Bhatty M; Sharma M
    Eur J Clin Microbiol Infect Dis; 2009 Sep; 28(9):1023-32. PubMed ID: 19373499
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Achromobacter xylosoxidans genomic characterization and correlation of randomly amplified polymorphic DNA profiles with relevant clinical features [corrected] of cystic fibrosis patients.
    Magni A; Trancassini M; Varesi P; Iebba V; Curci A; Pecoraro C; Cimino G; Schippa S; Quattrucci S
    J Clin Microbiol; 2010 Apr; 48(4):1035-9. PubMed ID: 20107101
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Detection of Achromobacter xylosoxidans in hospital, domestic, and outdoor environmental samples and comparison with human clinical isolates.
    Amoureux L; Bador J; Fardeheb S; Mabille C; Couchot C; Massip C; Salignon AL; Berlie G; Varin V; Neuwirth C
    Appl Environ Microbiol; 2013 Dec; 79(23):7142-9. PubMed ID: 24038696
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Distribution of the species of Achromobacter in a French Cystic Fibrosis Centre and multilocus sequence typing analysis reveal the predominance of A. xylosoxidans and clonal relationships between some clinical and environmental isolates.
    Amoureux L; Bador J; Bounoua Zouak F; Chapuis A; de Curraize C; Neuwirth C
    J Cyst Fibros; 2016 Jul; 15(4):486-94. PubMed ID: 26778615
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A novel bacterium Achromobacter xylosoxidans as a cause of liver abscess: three case reports.
    Asano K; Tada S; Matsumoto T; Miyase S; Kamio T; Sakurai K; Iida M
    J Hepatol; 2005 Aug; 43(2):362-5. PubMed ID: 15978693
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Epidemic Achromobacter xylosoxidans strain among Belgian cystic fibrosis patients and review of literature.
    Cools P; Ho E; Vranckx K; Schelstraete P; Wurth B; Franckx H; Ieven G; Van Simaey L; Van Daele S; Verhulst S; De Baets F; Vaneechoutte M
    BMC Microbiol; 2016 Jun; 16(1):122. PubMed ID: 27342812
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Mediastinitis superinfected by Achromobacter xylosoxidans. A case report.
    Marion-Sanchez K; Lion F; Olive C; Cailleaux G; Roques F
    J Infect Chemother; 2018 Dec; 24(12):987-989. PubMed ID: 29895453
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Multi-locus sequence analysis for identification of Achromobacter xylosoxidans from blood culture.
    Takei T; Konuma T; Takahashi S; Miharu Y; Suzuki M; Shibata H; Ishii H; Kato S; Takahashi S; Tojo A
    Infect Dis (Lond); 2016; 48(11-12):864-6. PubMed ID: 27376508
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.